-
1 week ago | 
thefishsite.com | Rob Fletcher
Founded by Andrew Peters and his wife, Sam, and now supported by Struan Coleman as their business partner, the company currently harvests between 40,000 and 50,000 scallops annually. Although their ambition is tempered by realism, they believe that their hard work is beginning to translate into a much more efficient farming model – one that they are now well placed to expand.
-
2 weeks ago | 
thefishsite.com | Rob Fletcher
Speaking to The Fish Site the day after the announcement, Nicki Holmyard, co-founder of the company, explained that while it felt too early to properly celebrate – as the precise details of the revised rules governing UK bivalve exports to Europe were not yet clear – the documents that she had seen so far did contain two bits of good news.
-
1 month ago | 
thefishsite.com | Rob Fletcher
Olstorpe’s initial venture, called Vegafish, was in business from 2014 until 2019. Despite the challenges that led to its closure, she argues that it was a successful proof-of-concept venture, which has provided invaluable experience. Called Håva, the new incarnation will consist of build a bigger and better biofloc system, with a new location on the coast.
-
1 month ago | 
thefishsite.com | Rob Fletcher
Returning to France after 13 years of trying to improve the sustainability of Chinese agriculture, Macquet was struck by how one of France’s most sustainable food production sectors – oyster farming – wasn’t inspiring the interest and recognition he was convinced it deserved.
-
1 month ago | 
thefishsite.com | Rob Fletcher
The US-based startup's phage platform targets pathogenic vibrios responsible early mortality syndrome (EMS) in shrimp and vibriosis in shrimp, oysters and finfish. The company is on the verge of securing regulatory approval in Mexico, where it also has its R&D headquarters, and expects is set to launch its first product in Mexico this year. Dr Loaiza believes the potential impact of this technology is substantial. “EMS can cause up to 85 percent mortality in hatcheries and grow-out farms.
-
1 month ago | 
thefishsite.com | Rob Fletcher
According to its supporters, the planned £350 million project would help to revitalise the archipelago’s struggling economy and create new employment opportunities in a community that’s over reliant on governmental jobs. However, recent history shows that there’s also vocal and effective opposition to aquaculture within the islands' 3,000-person population, leaving the fate of the project hanging in the balance.
-
2 months ago | 
thefishsite.com | Rob Fletcher
CAT’s CEO, John Buchanan; Matt Josephson, who has been responsible for the company’s editing work in Brazil; and ’s CEO, Ramon Amaral, recently explained the details of the deal, and its wider significance, to The Fish Site.
-
2 months ago | 
thefishsite.com | Rob Fletcher
These were some of the key points discussed during yesterday’s investment panel at the Blue Food innovation Summit in London. The panel featured a selection of investors: Maria Velkova, chief portfolio officer at Aqua-Spark; Alan Liu, vice-president of Novo Holdings; Jeroen van der Staay, executive director at Rabo Ventures; Claire Pribula, managing director and co-founder of The Yield Lab Asia-Pacific; and Nadir Ait-Laoussine, vice-president, platforms and programs, Sea Ahead.
-
2 months ago | 
thefishsite.com | Rob Fletcher
So prolific that it’s described as a weed (or simply weed) in many regions, hemp has had a long – and often complicated – shared history with humanity. It’s been vilified and venerated in equal measure for the psychotropic compounds contained in some strains of cannabis. Yet it’s a plant that has many more mundane yet potentially high impact – qualities that make it well suited both to provide an alternative to soy in aquafeeds and as a means to sequester carbon.
-
2 months ago | 
thefishsite.com | Rob Fletcher
The startup was founded in 2009 by Dr Charles Roe, a chemical engineer with experience at multinational companies including General Electric and ICI. “After my time at large corporations, I was recruited by a group of Procter and Gamble executives to start a global consulting company focused on open innovation and, ultimately, began to do some consulting in the algae and biotech spaces, before leaving to start AlgiSys,” explains Dr Roe.
